INBS NASDAQ
Intelligent Bio Solutions Inc.
1W: -2.4%
1M: -32.8%
3M: -27.2%
YTD: -79.0%
1Y: -84.0%
3Y: -98.8%
5Y: -100.0%
$1.66
+0.00 (+0.00%)
Weekly Expected Move ±5.6%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-04-02
Earliest Filing
2024-03-01
Latest Filing
partner: 5
acquirer: 1
target: 1
Counterparties (Filed by INBS)
7 relationshipsCompanies named in INBS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. | INBS | acquirer | Company entering consulting agreement | 2024-03-01 | View |
| C2C Advisors Inc. | — | partner | Consultant providing marketing and advisory services | 2024-03-01 | View |
| AJO Capital INC | — | partner | Predecessor party referenced in agreement supersession clause | 2024-03-01 | View |
| Intelligent Fingerprinting Limited | INTC | target | Target of proposed acquisition by GBS Inc. via exclusivity agreement. | 2022-06-17 | View |
| Life Science Biosensor Diagnostics Pty Ltd | — | partner | Licensor granting options and licenses to GBS and BSX | 2021-04-02 | View |
| GBS Inc | — | partner | Option holder and licensee for Glucose Field | 2021-04-02 | View |
| BiosensX (North America) Inc | — | partner | Existing licensee for non-Glucose Field and target for license restructuring | 2021-04-02 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-11 | Other Events | View | |
| 2026-09-09 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-02 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-09-01 | Regulation FD; Exhibits | View | |
| 2026-08-28 | Regulation FD; Exhibits | View | |
| 2026-08-19 | Earnings Release; Exhibits | View | |
| 2026-08-11 | Regulation FD; Exhibits | View | |
| 2026-08-05 | Regulation FD; Exhibits | View | |
| 2026-08-03 | Regulation FD; Exhibits | View | |
| 2026-08-03 | Other Events | View | |
| 2026-07-23 | Regulation FD; Exhibits | View | |
| 2026-07-21 | Regulation FD; Exhibits | View | |
| 2026-06-16 | Regulation FD; Exhibits | View | |
| 2026-06-02 | Regulation FD; Exhibits | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-04-20 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-23 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-02-25 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR